Project Number EUJPND-CIHR-Chertkow-373 Agency/Funding Organization Canadian Institutes of Health Research (CIHR) Funding Year 2016 View Full Project Details for Typical and atypical Alzheimer Disease: salivary tau biomarkers, therapy with neuromodulation, and disease subtypes. Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 1. Fluid Biomarkers d. Saliva-based Biomarkers Researcher and Organization Principal Investigator Chertkow, Howard M Principal Investigator First Name Howard M Principal Investigator Last Name Chertkow Awardee Organization Jewish General Hospital (Montreal) Contact PI Country Canada Project Detail FY Overall Cost $157,336 Funding Organization Agency/Funding Organization Canadian Institutes of Health Research (CIHR) Funding Organization Country Canada Special Initiative EU Joint Programme - Neurodegenerative Disease Research - Research Mapping (2016)
